|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 978.31 USD | -2.15% |
|
-0.76% | -9.21% |
| 09:07pm | Eli Lilly's Japanese Unit to Invest $126 Million to Bolster Capacity at Kobe Facility | MT |
| 08:41pm | Abivax spokesperson denies La Lettre reports |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 29.39x | 18.11x | 0.61x | 11.07x | 22.23x | 23.68x | 0.66% | 89TCr | ||
| 25.78x | 6.69x | -1.77x | 6x | 16.34x | 18.05x | 2.18% | 59TCr | ||
| 24.73x | 71.39x | 0.09x | 6.77x | 13.58x | 13.93x | 3.04% | 40TCr | ||
| 17.77x | 6.22x | 1.13x | 4.33x | 10.71x | 12.13x | 3.05% | 34TCr | ||
| 24.42x | 5.53x | 1.13x | 5.09x | 14.09x | 15.12x | 1.71% | 30TCr | ||
| 21.17x | 6.26x | 11.6x | 5.7x | 14.1x | 15.08x | 2.84% | 30TCr | ||
| 27.16x | 5.08x | -0.66x | 4.76x | 14.89x | 17.58x | 2.9% | 29TCr | ||
| 25.41x | 17.06x | 5.7x | 6.42x | 11.43x | 14.59x | 2.66% | 20TCr | ||
| 20.24x | 6.86x | 3.16x | 6.16x | 11.14x | 13.11x | 2.23% | 18TCr | ||
| 11.75x | 5.06x | -1.53x | 4.26x | 8.84x | 10.31x | 4.28% | 17TCr | ||
| 12.77x | 1.71x | 0.22x | 3.23x | 7.7x | 9.1x | 6.44% | 16TCr | ||
| 28.04x | 5.52x | 1.92x | 8.57x | 19.13x | 19.87x | -.--% | 13TCr | ||
| 11.99x | 5.24x | 0.27x | 3.15x | 8.49x | 9.12x | 4.19% | 12TCr | ||
| 12.96x | 4.4x | 1x | 2.8x | 8.11x | 9.31x | 3.35% | 11TCr | ||
| 12.01x | 1.18x | -15.62x | 2.2x | 7.24x | 7.87x | 5.55% | 11TCr | ||
| 36.39x | 7.87x | 3.47x | 11.77x | 23.14x | 24.67x | 2.68% | 9.81TCr | ||
| 51.47x | 1.31x | 0.81x | 2.87x | 10.65x | 30.21x | 3.48% | 5.72TCr | ||
| 42.94x | 6.08x | 1.43x | 10.05x | 33.97x | 35.32x | 0.47% | 5.39TCr | ||
| 32.39x | 1.38x | -0.24x | 1.57x | 7.54x | 12.71x | 0.55% | 4.55TCr | ||
| Average | 24.67x | 9.63x | 0.67x | 5.62x | 13.86x | 16.41x | 2.75% | 23.87TCr | |
| Weighted average by Cap. | 24.16x | 14.32x | 0.92x | 6.56x | 15.09x | 16.78x | 2.42% |
- Stock Market
- Equities
- LLY Stock
- Sector Eli Lilly and Company
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















